1. IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Arteries. Issue 3 (20th December 2021) Authors: Corban, Michel T.; Toya, Takumi; Albers, Diana; Sebaali, Faten; Lewis, Bradley R.; Bois, John; Gulati, Rajiv; Prasad, Abhiram; Best, Patricia J.M.; Bell, Malcolm R.; Rihal, Charanjit S.; Prasad, Megha; Ahmad, Ali; Lerman, Lilach O.; Solseth, Mary L.; Winters, Jeffrey L.; Dietz, Allan B.; Lerman, ... Journal: Circulation research Issue: Volume 130:Issue 3(2022) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Arteries. Issue 3 (4th February 2022) Authors: Corban, Michel T.; Toya, Takumi; Albers, Diana; Sebaali, Faten; Lewis, Bradley R.; Bois, John; Gulati, Rajiv; Prasad, Abhiram; Best, Patricia J.M.; Bell, Malcolm R.; Rihal, Charanjit S.; Prasad, Megha; Ahmad, Ali; Lerman, Lilach O.; Solseth, Mary L.; Winters, Jeffrey L.; Dietz, Allan B.; Lerman, ... Journal: Circulation research Issue: Volume 130:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗